During open enrollment, choose San Diego's best health care. Get started.

About Dimitrios Tzachanis, MD, PhD

Dimitrios Tzachanis, MD, PhD, is a board-certified hematologist and medical oncologist who specializes in treating people with cancers of the blood and lymph system, including lymphoma, myeloma, leukemia, myelodysplastic syndromes (MDS) and myeloproliferative neoplasms (MPN). He is a transplant physician for the joint UC San Diego Health / Sharp HealthCare Blood and Marrow Transplantation (BMT) Program, which provides comprehensive blood and marrow transplant services, including autologous and allogeneic stem cell transplantation.

Dr. Tzachanis offers chimeric antigen receptor (CAR) T-cell therapy to adults with relapsed or refractory B-cell lymphoma, a type of non-Hodgkin lymphoma. CAR T-cell therapy harnesses the patient's own immune cells to recognize and kill cancer cells. It is just one of many types of personalized cancer therapies offered at UC San Diego Health.

As a professor in the Department of Medicine at UC San Diego School of Medicine, Dr. Tzachanis instructs medical students, residents and fellows. His research interests lie primarily in cancer immunology and immunotherapy. He has published more than sixty peer-reviewed articles in prestigious medical journals such as the New England Journal of Medicine, the Lancet, Blood, Nature Immunology, and Bone Marrow Transplantation, among others.

Prior to joining UC San Diego Health, Dr. Tzachanis was a staff physician at Cedars-Sinai Medical Center and USC Norris Comprehensive Cancer Center in Los Angeles and at Beth Israel Deaconess Medical Center in Boston. He has served as an assistant professor at UCLA and USC and as an instructor of medicine at Harvard Medical School.

Dr. Tzachanis completed a research and clinical fellowship in hematology and oncology at the Beth Israel Deaconess Medical Center and Harvard Medical School in Boston. He completed his residency in internal medicine at Dartmouth-Hitchcock Medical Center in Lebanon, N.H. Dr. Tzachanis earned his medical degree from the Aristotelian University School of Medicine in Thessaloniki, Greece, and a doctorate in medical immunology from the University of Athens School of Medicine. He is board certified in hematology and medical oncology.

Dr. Tzachanis is a member of several professional societies, including the American Society of Hematology and the American Society of Bone Marrow Transplantation. He has been elected as a top physician by several surveys such as the Best Doctors in America®, the San Diego Magazine and Castle Connolly.

UC San Diego Health Links
For more information, see Blood Cancers and Cancer Care.

DegreeAristotle University of Thessaloniki, GreeceResidencyDartmouth Medical School, Dartmouth-Hitchcock Medical Center, Lebanon, NHFellowshipHarvard Medical School, Beth Israel Deaconess Medical Center, Boston, MA
GenderMale
LanguagesGermanGreek
Date Joined Staff2015-11-01
Board Certifications
American Board of Internal MedicineHematologyMedical Oncology
Conditions and Treatments
  • Myelodysplastic Syndromes (MDS)
  • Myeloma
  • Myeloproliferative Neoplasms
  • Blood Cancer
  • Leukemia
  • Lymphoma
  • Multiple Myeloma
  • Chimeric Antigen Receptor (CAR) T-Cell Therapy
  • Blood and Marrow Stem Cell Transplantation
  • Stem Cells
  • Cancer Immunotherapy
  • Graft Versus Host Disease
  • Allogeneic Stem Cell Transplant
  • Autologous Stem Cell Transplant
Cancer

Is My Insurance Accepted?

We accept most major insurance plans at UC San Diego Health. Find out if your insurance is accepted.

News

Health Cancer Man Beach
Cancer Care as Unique as You

Choose UC San Diego Health for truly personalized cancer care at San Diego's only Comprehensive Cancer Center.

Open Payments Program Notification

For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.

View Open Payments Data for Dr. Tzachanis